Future Market Insights delivers key insights on the global anti-counterfeit pharmaceutical packaging market in a new report titled, “Anti-counterfeit Pharmaceutical Packaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2026”. The global anti-counterfeit pharmaceutical packaging market is projected to register a healthy CAGR of 12.1% during the forecast period 2016-2026. The report provides insightful information on the global anti-counterfeit pharmaceutical packaging market pertaining to the market trends, competitive landscape, market dynamics, and market estimation and forecast for the projected ten-year period.
Demand for safe packaging to combat illicit drug market is increasing. A large portion of all pharmaceutical formulations available in the market are counterfeit. The current market size of counterfeit drugs is more than US$ 80 bn. This poses a threat to the global pharmaceutical market. The counterfeited pharmaceutical products affect both, i.e. patients as well as pharma companies with their brand reputation. More than 30% of total pharmaceutical products in developing markets are counterfeited and approximately 15% drugs sold across several sales channel in developed markets are fake. The rampant counterfeiting of drugs has pushed pharma producers to opt for secure solutions. Anti-counterfeiting packaging is one of the measures that pharma majors are relying on. Pharmaceutical companies have been incorporating anti-counterfeit solutions with their product packages; of these, hologram, barcode, and water is common and considered as a conventional option for the same. However, with advancement in technology, pharmaceutical manufacturers are also integrating new and innovative options with conventional solutions such as integrating authentication overt features with covert elements, forensics, and track & trace elements. These measures have translated into fruitful results for pharmaceutical companies and tier II pharma companies also prefer similar approaches. These effective measures considered by pharma companies resulted in the sudden increase in demand for anti-counterfeit pharmaceutical packaging across the globe.
The WHO and FDA’s efforts to ensure safe-conduct practices across the pharmaceutical industry value chain by integrating advanced anti-counterfeit packaging technology encouraged pharma manufacturers to explore new possibilities. This, in turn, is creating value for suppliers of anti-counterfeit packaging technology to the pharmaceutical industry. The anti-counterfeit pharmaceutical packaging market is responding with positive growth rate, which is likely to continue during the forecast period.
Global anti-counterfeit pharmaceutical packaging is segmented on the basis of usage feature (convert features, divert features, forensic markers, tamper evidence and track & trace technologies- [sterilization and identification system]) and technology (RFID- [active tags, passive tags, semi-active tags], security inks and coatings, security printing and graphics, Hologram, Mass Encoding-[ Barcode Application, Digital Mass Serialization, Digital Mass Encryption], Others- [Electromagnetic, surveillance technologies]).
On the basis of usage feature, the track & trace technologies segment is anticipated to account for US$ 2,742.5 Mn by 2026, registering a substantially high CAGR of 13.1% over the forecast period with a relatively high value share of 35.8% by 2026. The convert feature segment is expected to follow closely with a value share of 13.9% by 2026 and a CAGR of 12.3%. Revenue share of forensic makers segment is expected to decrease from 8.5% in 2016 over 7.4% in 2026, registering a CAGR of 10.7%.
On the basis of technology, the security printing and graphics segment is anticipated to account for US$ 3768.5 Mn by 2026, registering a substantially high CAGR of 12.8% over the forecast period with a value share of 12.2%. The RFID and security inks and coatings segment is expected to follow closely with a value share of 18.2% and 12.4% respectively by 2026. Revenue share of security printing and graphics is expected to increase from 32.0% in 2016 over 32.4% in 2026, with CAGR of 12.3 %.
The report covers the global anti-counterfeit pharmaceutical packaging market across seven key regions namely – North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific Excl. Japan (APEJ), and the Middle East and Africa (MEA). On the basis of region, North America region is projected to remain dominant in anti-counterfeit pharmaceutical packaging market throughout the forecast period. Anti-counterfeit pharmaceutical packaging in North America region is estimated to account for the largest market share of 34.1% in 2016 which is expected to decrease to 33.3% by 2026 at the CAGR of 11.9%. Anti-counterfeit pharmaceutical packaging is expected to witness robust growth in the APAC market driven by increasing demand for anti-counterfeit measures in the region and the market is growing at the CAGR of 18.9 % over the forecast period. Latin America is projected to be the fastest growing market over the forecast period, with a CAGR of 12.7%. In MEA region the changing economic profile of Africa is influencing local as well as international players to expand in the region. The anti-counterfeit pharmaceutical market in Middle East & Africa is estimated to expand at a fast-paced CAGR of 11.5% by 2026 owing to the growth in economy of the region.
The report also profiles some of the leading anti-counterfeit pharmaceutical packaging manufacturers operating in the global anti-counterfeit pharmaceutical packaging market. Key market players featured in the report include 3M trace & trace solution, Avery Dennison Corp., Alien Technology, Authentix, Digimarc Impinj Inc, ATL Security Label Systems , Sicpa Holdings, CFC international and Applied DNA sciences
Request For Report Sample With Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-2385
